Coston McIsaac & Partners’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57K Buy
620
+3
+0.5% +$279 0.01% 322
2026
Q1
$60K Buy
617
+2
+0.3% +$183 0.01% 295
2025
Q4
$54K Sell
615
-29
-5% -$2.64K 0.01% 304
2025
Q3
$57K Buy
644
+3
+0.5% +$243 0.01% 284
2025
Q2
$48K Buy
641
+3
+0.5% +$223 0.01% 304
2025
Q1
$45K Buy
638
+2
+0.3% +$156 0.01% 287
2024
Q4
$55K Buy
636
+2
+0.3% +$175 0.02% 263
2024
Q3
$53K Buy
634
+2
+0.3% +$160 0.02% 270
2024
Q2
$48K Buy
632
+3
+0.5% +$222 0.02% 271
2024
Q1
$45K Sell
629
-45
-7% -$3.23K 0.01% 287
2023
Q4
$50K Buy
674
+35
+5% +$2.5K 0.02% 256
2023
Q3
$43K Buy
639
+3
+0.5% +$216 0.02% 259
2023
Q2
$46K Buy
636
+4
+0.6% +$300 0.02% 283
2023
Q1
$47K Buy
632
+4
+0.6% +$307 0.02% 267
2022
Q4
$48K Buy
628
+4
+0.6% +$310 0.02% 267
2022
Q3
$46K Buy
624
+2
+0.3% +$162 0.02% 224
2022
Q2
$47K Buy
+622
New +$49.9K 0.03% 139

Other funds holding SRE

Coston McIsaac & Partners's SRE Position: Q2 2026 in Review

Coston McIsaac & Partners increased its Sempra (SRE) stake by 0.49% in Q2 2026, buying an estimated $279 and bringing the position to 620 shares worth $57K. The position accounts for 0.01% of the portfolio, ranked #322.

Coston McIsaac & Partners first reported a position in SRE in Q2 2022 and has held it in 17 quarters since. The position peaked at $60K in Q1 2026. 1,282 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Coston McIsaac & Partners held 620 shares of Sempra worth $57K as of Q2 2026.
  • Coston McIsaac & Partners bought 3 Sempra shares in Q2 2026, an estimated $279.
  • Sempra made up 0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #322 holding.
  • Coston McIsaac & Partners first reported a position in Sempra in Q2 2022 and has held it in 17 quarters since.
  • Coston McIsaac & Partners's Sempra position peaked at $60K in Q1 2026.
  • 1,282 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.